Position：Vice Chair of Gynecology
Department：Gynecology
Medical School：Zhejiang University School of Medicine, China
Academic Rank：Chief Physician
Diagnosis and treatment of endometriosis and gynecological tumors with minimally invasive techniques, especially the laparoscopic surgery for difficult hysterectomy, complex pelvic endometriosis and ovarian cancer.
Best Surgical Skill Award, National Experience Sharing Conference on Laparoscopic Surgery
Operation Video Contest of the First Annual Meeting of Gynecological Oncology of Zhejiang Medical Association, Second Prize
Professional Award for Science and Technology Innovation of Zhejiang Province, Third Prize
Vice Chairman, Pelvic Floor Rehabilitation Committee, China Maternal and Child Health Association
Member, Gynecological Oncology Group, China Medical Care Exchange Promotion Association
Member, Tumor Reproduction Branch, China Healthy Birth Science Association
Member, Gynecological Oncology Branch, Zhejiang Medical Association
Deputy Leader, Colposcopy and Cervical Pathology Group, Gynecological Oncology Branch, Zhejiang Medical Association
Deputy Director, Day Surgery Diagnosis and Treatment Committee, Zhejiang Maternal and Child Health Association
Member, Minimally Invasive Group, Chinese Medical Association
Member, Zhejiang Endometriosis Cooperative Group
Member, 7th Professional Committee of Obstetrics and Gynecology, Zhejiang Society of Traditional Chinese and Western Medicine
The tumor microenvironment is a hot spot in the field of immune research. The M1 Macrophages show high pro-inflammatory and antigen-presenting abilities and host immune scavenging activity against tumor cells. Dr. Zhou's previous study found that LincAM1T expression was significantly up-regulated in M1 macrophages and LincAM1T was hypothesized to inhibit epithelial ovarian cancer by inducing macrophage M1 polarization. Thus, Dr. Zhou's team is trying to explore the molecular mechanism by which LincAM1T induces macrophage M1 polarization to inhibit the progression of epithelial ovarian cancer.
Pan T#, Liu J#, Xu S, Yu Q, Wang H, Sun H, Wu J, Zhu Y, Zhou J*, Zhu Y*. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells. Theranostics. 2020, 10:516-536.
Yu S#, Shen J#, Fei J, Zhu X, Yin M, Zhou J*. KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors. Oncotargets Therapy. 2020,13: 709–718.
Zhu Y, Zhang Z, Jiang Z, Liu Y, Zhou J*. CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment. Front Genet. 2020 Apr 30;11:369.
Yin M, Shen J, Yu S, Fei J, Zhu X, Zhao J, Zhai L, Sadhukhan A, Zhou J*. Tumor associated macrophages (TAMs): a critical activator in ovarian metastasis. Oncotargets Therapy. 2019, 12:8687-8699.
Shen J, Yu S, Sun X, Yin M, Fei J, Zhou J*. Identification of Key Biomarkers Associated With Development and Prognosis in Patients With Ovarian Carcinoma: Evidence From Bioinformatic Analysis. J Ovarian Res. 2019 Nov 15;12(1):110.
Shen J, Zhu X, Fei J, Shi P, Yu S, Zhou J*. Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect. Oncotargets Therapy. 2018, 11: 2831-2841.
Zhang W#, Fei J#, Yu S, Shen J, Zhu X, Sadhukhan A, Lu W*, Zhou J*. LINC01088 inhibits tumorigenesis of ovarian epithelial cells by targeting miR-24-1-5p. Sci Rep. 2018, 8:2876.
Lin H, Ding Z, Kota VG, Zhang X, Zhou J*. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Oncotarget. 2017, 8:46601-46610.
88 Jiefang Road,Shangcheng District Hangzhou,China, 310009
1511 Jianghong Road,Binjiang District Hangzhou,China, 310014
300 Yuanju Road, Shangcheng DIstrict, Hangzhou
456 Qidi Road, Xiaoshan District, Hangzhou, China
1 Xihu Avenue, Shangcheng District, Hangzhou
Zijingang Campus of Zhejiang University, 866 Yuhangtang Road, Xihu District, Hangzhou
Please call +86-571-8971 3988 (8am-5pm, Monday through Friday)
Make an appointment online
The Second Affiliated Hospital
Zhejiang University School of Medicine
88 Jiefang Road, Hangzhou, China
+86-571-8731 5108
iao_sahzu@zju.edu.cn
The Needs of Patients and Customers Come First.
The Second Affiliated Hospital Zhejiang University School of Medicine
All Rights Reserved.
